Patents by Inventor Nils Pemberton

Nils Pemberton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE GAMMA
    Publication number: 20210047312
    Abstract: There are disclosed certain novel compounds (including pharmaceutically acceptable salts thereof), that inhibit phosphatidylinositol 3-kinase gamma (PI3K?) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: November 4, 2020
    Publication date: February 18, 2021
    Applicant: AstraZeneca AB
    Inventors: Mickael MOGEMARK, Nils PEMBERTON, Jens PETERSEN, Matthew PERRY, Konstantinos KARABELAS, Pavol ZLATOIDSKY, Rhona COX, Christian TYRCHAN
  • Inhibitors of phosphatidylinositol 3-kinase gamma
    Patent number: 10858355
    Abstract: There are disclosed certain novel compounds (including pharmaceutically acceptable salts thereof), that inhibit phosphatidylinositol 3-kinase gamma (PI3K?) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: December 8, 2020
    Assignee: AstraZeneca AB
    Inventors: Mickael Mogemark, Nils Pemberton, Jens Petersen, Matthew Perry, Konstantinos Karabelas, Pavol Zlatoidsky, Rhona Cox, Christian Tyrchan
  • NOVEL INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE GAMMA
    Publication number: 20200299289
    Abstract: There are disclosed certain novel compounds (including pharmaceutically acceptable salts thereof), that inhibit phosphatidylinositol 3-kinase gamma (P13K?) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 24, 2020
    Applicant: AstraZeneca AB
    Inventors: Mickael MOGEMARK, Nils PEMBERTON, Jens PETERSEN, Matthew PERRY, Konstantinos KARABELAS, Pavol ZLATOIDSKY, Rhona COX, Christian TYRCHAN
  • Amino methylated 2-pyridinones
    Patent number: 7915417
    Abstract: Novel amino methylated 2-pyridinones, precursors, intermediates, and derivatives; the methods for the preparation of the same; uses of the same for inhibiting pili formation in bacteria; and pharmaceutical compositions comprising these compounds are described in this application. The present compounds may be employed to inhibit biofilm formation and thereby inhibit adherence of bacteria to a host cell.
    Type: Grant
    Filed: August 11, 2008
    Date of Patent: March 29, 2011
    Assignee: Washington University
    Inventors: Scott J. Hultgren, Jerome S. Pinkner, Fredrik Almqvist, Nils Pemberton, Veronica Aberg, Andreas Larsson
  • Amino Methylated 2-Pyridinones
    Publication number: 20080311644
    Abstract: Novel amino methylated 2-pyridinones, precursors, intermediates, and derivatives; the methods for the preparation of the same; uses of the same for inhibiting pili formation in bacteria; and pharmaceutical compositions comprising these compounds are described in this application. The present compounds may be employed to inhibit biofilm formation and thereby inhibit adherence of bacteria to a host cell.
    Type: Application
    Filed: August 11, 2008
    Publication date: December 18, 2008
    Applicant: WASHINGTON UNIVERSITY
    Inventors: Scott J. Hultgren, Jerome S. Pinkner, Fredrik Almqvist, Nils Pemberton, Veronica Aberg, Andreas Larsson
  • Amino methylated 2-pyridinones
    Patent number: 7411066
    Abstract: Novel amino methylated 2-pyridinones, precursors, intermediates, and derivatives; the methods for the preparation of the same; uses of the same for inhibiting pili formation in bacteria; and pharmaceutical compositions comprising these compounds are described in this application. The present compounds may be employed to inhibit biofilm formation and thereby inhibit adherence of bacteria to a host cell.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: August 12, 2008
    Assignee: Washington University
    Inventors: Scott J. Hultgren, Jerome S. Pinkner, Fredrik Almqvist, Nils Pemberton, Veronica Aberg, Andreas Larsson
  • Amino methylated 2-pyridinones
    Publication number: 20070082887
    Abstract: Novel amino methylated 2-pyridinones, precursors, intermediates, and derivatives; the methods for the preparation of the same; uses of the same for inhibiting pili formation in bacteria; and pharmaceutical compositions comprising these compounds are described in this application. The present compounds may be employed to inhibit biofilm formation and thereby inhibit adherence of bacteria to a host cell.
    Type: Application
    Filed: October 16, 2006
    Publication date: April 12, 2007
    Applicant: Washington University
    Inventors: Scott Hultgren, Jerome Pinkner, Fredrik Almqvist, Nils Pemberton, Veronica Aberg, Andreas Larsson